Skip to main content

Targeted Cancer Therapy

  • Book
  • © 2008

Overview

  • Will optimize the reader's ability to prescribe effective therapeutic regimens
  • Provides know-how on building drug combinations that overcome disease resistance
  • Illustrates the use of personalized medicine in cancer treatment
  • Divided into clearly organized, site specific chapters
  • Presents the forefront in the practical implementation of targeted therapeutics

Part of the book series: Current Clinical Oncology (CCO)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (20 chapters)

Keywords

About this book

In the era of personalized medicine, cancer treatment has become a model for the use of targeted therapeutics. Leaving behind the "one size fits all" approach to cancer care, this book provides the practicing oncologist with an overview of the advances in treatment and an understanding of the implementation of new therapeutic agents. Targeted Cancer Therapy is divided into twenty chapters covering specific hematologic malignancies and solid tumors, targeted and functional imaging, and combination therapies. Each disease specific chapter includes up-to-date information on investigational and FDA approved therapies which will enhance the reader’s ability to prescribe effective drug regimens. This includes combinations of therapies and therapeutic modalities to overcome drug resistance.

In a rapidly changing field, this book will enable clinicians to improve their ability to practice personalized health planning, make early diagnoses, and select optimal drugs for each patient with predictable side effects and outcomes. Poised to change the landscape in oncology, Targeted Cancer Therapy is essential for practicing and academic physicians, fellows, and residents.

Reviews

From the reviews:

“Targeted Cancer Therapy provides an overview of recent advancements in therapy deriving from the implementation of new therapeutic agents. … this book represents a useful and stimulating publication. … the book has a scientific and cultural appeal for many other professionals interacting with patients with neoplastic disease. … we also suggest this volume to all students who want to grow into becoming protagonists in the new era of molecular medicine.” (Luigi Mansi and Andrea Vaccaro, European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, 2012)

Editors and Affiliations

  • Department of Investigational Cancer Therapeutics Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston

    Razelle Kurzrock

  • Department of Clinical Research, The University of Texas MD Anderson Cancer Center, Houston

    Maurie Markman

Bibliographic Information

  • Book Title: Targeted Cancer Therapy

  • Editors: Razelle Kurzrock, Maurie Markman

  • Series Title: Current Clinical Oncology

  • DOI: https://doi.org/10.1007/978-1-60327-424-1

  • Publisher: Humana Totowa, NJ

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Humana Press 2008

  • Hardcover ISBN: 978-1-60327-423-4Published: 07 April 2008

  • Softcover ISBN: 978-1-60761-598-9Published: 09 December 2009

  • eBook ISBN: 978-1-60327-424-1Published: 07 March 2008

  • Series ISSN: 2364-1134

  • Series E-ISSN: 2364-1142

  • Edition Number: 1

  • Number of Pages: XII, 446

  • Number of Illustrations: 16 b/w illustrations, 16 illustrations in colour

  • Topics: Oncology, Hematology, Cancer Research, Internal Medicine

Publish with us